Canada places USD 56m monkeypox vaccine order at Bavarian Nordic

The Canadian Government has signed a multi-year contract with Bavarian Nordic for supplies of its monkeypox vaccine. The contract has an estimated value of USD 56m.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analyst spots more monkeypox opportunities for Bavarian
For subscribers